Biopharmaceuticals Manufacturing Consumables Testing Market by Product Type (Consumables, Instruments, Services), Type (Compendial Testing, Custom Testing, Laboratory Testing), Application - Global Forecast 2023-2030
The Biopharmaceuticals Manufacturing Consumables Testing Market is projected to reach USD 1,213.54 million by 2030 from USD 504.15 million in 2022, at a CAGR of 11.60% during the forecast period.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Biopharmaceuticals Manufacturing Consumables Testing Market.
- Based on Product Type, market is studied across Consumables, Instruments, and Services. The Services is projected to witness significant market share during forecast period.
- Based on Type, market is studied across Compendial Testing, Custom Testing, and Laboratory Testing. The Laboratory Testing is further studied across Chemical Analysis Testing, Enzyme Testing, Stability Testing, and Sterility Testing. The Custom Testing is projected to witness significant market share during forecast period.
- Based on Application, market is studied across Biopharmaceuticals Production, Quality Control & Assurance, and Research & Development. The Research & Development is projected to witness significant market share during forecast period.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Biopharmaceuticals Manufacturing Consumables Testing Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Biopharmaceuticals Manufacturing Consumables Testing Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Biopharmaceuticals Manufacturing Consumables Testing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Alcami Corporation, Almac Group Limited, ALS Limited, ASTM International, Avance Biosciences, Inc., Becton, Dickinson and Company, BioConvergence LLC, BioLife Solutions Inc., bioMérieux SA, Boston Analytical, Inc., Bureau Veritas SA, Catalent, Inc, Charles River Laboratories International, Inc., Curia Global, Inc., DEKRA SE, EM Topco Limited, Eurofins Scientific SE, Intertek Group PLC, Laboratory Corporation of America, LGM Pharma, LLC, Life Technologies (India) Pvt Ltd., Merck KGaA, MISTRAS Group, Inc., Neopharm Labs Inc., Ortho-Clinical Diagnostics, Inc., Pace Analytical Services, LLC, Pacific BioLabs, Inc., ProtaGene, GmbH., Sartorius AG, SGS SA, Sotera Health Company, STERIS PLC, Tentamus Group GmbH, Thermo Fisher Scientific Inc., TÜV SÜD ELAB GmbH, and WuXi AppTec, Inc..
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Biopharmaceuticals Manufacturing Consumables Testing Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Biopharmaceuticals Manufacturing Consumables Testing Market?
- What is the competitive strategic window for identifying opportunities in the Biopharmaceuticals Manufacturing Consumables Testing Market?
- What are the latest technology trends and regulatory frameworks in the Biopharmaceuticals Manufacturing Consumables Testing Market?
- What is the market share of the leading vendors in the Biopharmaceuticals Manufacturing Consumables Testing Market?
- Which modes and strategic moves are suitable for entering the Biopharmaceuticals Manufacturing Consumables Testing Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Biopharmaceuticals Manufacturing Consumables Testing Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing demand for biopharmaceutical products
- 5.1.1.2. Stringent regulatory requirements for quality assurance and safety of biopharmaceutical consumables
- 5.1.2. Restraints
- 5.1.2.1. High costs associated with deployment of testing equipment
- 5.1.3. Opportunities
- 5.1.3.1. Advancements in technologies for efficient biopharmaceutical consumables testing
- 5.1.3.2. Growing expansion of biopharmaceutical industry across economies
- 5.1.4. Challenges
- 5.1.4.1. Adapting to evolving regulations and standards across regions
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. Biopharmaceuticals Manufacturing Consumables Testing Market, by Product Type
- 6.1. Introduction
- 6.2. Consumables
- 6.3. Instruments
- 6.4. Services
- 7. Biopharmaceuticals Manufacturing Consumables Testing Market, by Type
- 7.1. Introduction
- 7.2. Compendial Testing
- 7.3. Custom Testing
- 7.4. Laboratory Testing
- 7.5.1. Chemical Analysis Testing
- 7.5.2. Enzyme Testing
- 7.5.3. Stability Testing
- 7.5.4. Sterility Testing
- 8. Biopharmaceuticals Manufacturing Consumables Testing Market, by Application
- 8.1. Introduction
- 8.2. Biopharmaceuticals Production
- 8.3. Quality Control & Assurance
- 8.4. Research & Development
- 9. Americas Biopharmaceuticals Manufacturing Consumables Testing Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Biopharmaceuticals Manufacturing Consumables Testing Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Biopharmaceuticals Manufacturing Consumables Testing Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Agilent Technologies, Inc.
- 13.1.2. Alcami Corporation
- 13.1.3. Almac Group Limited
- 13.1.4. ALS Limited
- 13.1.5. ASTM International
- 13.1.6. Avance Biosciences, Inc.
- 13.1.7. Becton, Dickinson and Company
- 13.1.8. BioConvergence LLC
- 13.1.9. BioLife Solutions Inc.
- 13.1.10. bioMérieux SA
- 13.1.11. Boston Analytical, Inc.
- 13.1.12. Bureau Veritas SA
- 13.1.13. Catalent, Inc
- 13.1.14. Charles River Laboratories International, Inc.
- 13.1.15. Curia Global, Inc.
- 13.1.16. DEKRA SE
- 13.1.17. EM Topco Limited
- 13.1.18. Eurofins Scientific SE
- 13.1.19. Intertek Group PLC
- 13.1.20. Laboratory Corporation of America
- 13.1.21. LGM Pharma, LLC
- 13.1.22. Life Technologies (India) Pvt Ltd.
- 13.1.23. Merck KGaA
- 13.1.24. MISTRAS Group, Inc.
- 13.1.25. Neopharm Labs Inc.
- 13.1.26. Ortho-Clinical Diagnostics, Inc.
- 13.1.27. Pace Analytical Services, LLC
- 13.1.28. Pacific BioLabs, Inc.
- 13.1.29. ProtaGene, GmbH.
- 13.1.30. Sartorius AG
- 13.1.31. SGS SA
- 13.1.32. Sotera Health Company
- 13.1.33. STERIS PLC
- 13.1.34. Tentamus Group GmbH
- 13.1.35. Thermo Fisher Scientific Inc.
- 13.1.36. TÜV SÜD ELAB GmbH
- 13.1.37. WuXi AppTec, Inc.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook